This website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
This Website Uses Cookies By closing this message or continuing to use our site, you agree to our cookie policy. Learn MoreThis website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
We all reach moments of reflection. An incident or series of events that makes you take a breath, step back and evaluate what has gone by and what might be to come. As a nation, we’ve had too many of these moments in the last few months.
In 2020 the Healthcare Compliance Packaging Council celebrates its 30th anniversary. In that time, HCPC has witnessed dramatic changes in the pharmaceutical market, and our mission has evolved to meet the changing landscape of the healthcare industry.
In the position, Hideo (Harry) Yonenaga will assume full business responsibility for the growth and expansion of MHI’s advanced line of blister packaging machines.
Driven by increasingly complex supply chains, a lack of enforcement capacity, the expansion of ecommerce and more sophisticated counterfeiters and counterfeiting methods, the FDA estimates that approximately 10% of all pharmaceuticals currently sold globally are illicit.
As 2017 heads toward the final quarter and the time intended for the Drug Supply Chain Security Act (DSCSA) to implement step 1, i.e., all pharma manufacturers distributing only serialized primary containers into the supply chain, we’ve learned a few things.
Pharmaceutical companies continue to adapt to regulations like the FDA’s Drug Supply Chain Security Act (DSCSA) and 21 CFR Part 11.More and more manufacturers are looking at labeling to provide an edge in the face of these challenges.
In 1970, Richard Nixon signed into law the Poison Prevention Packaging Act (PPPA). The act was written in response to a growing number of child poisonings from unintentional ingestion of drugs and other products. The Act was successful, but a lot has changed in the last 47 years.